Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
Memorial Sloan-Kettering Cancer Center, New York, New York Taylor Cancer Research Center, Maumee, Ohio SCRI Oncology Partners, Nashville, Tennessee START Mountain Region, West Valley City, Utah NEXT Virginia, Fairfax, Virginia